Par Pharmaceutical Companies, Inc. is a privately held, U.S.-based specialty pharmaceutical company that develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals through its wholly-owned subsidiary’s two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals. Par is a portfolio company of TPG, a leading global private investment firm with $55.7 billion of assets under management and with extensive experience in the healthcare sector.
The following is the list of scholars from PAR Sterile Products who currently serve as editors for one or more SciTechnol journals.
The following is the list of articles by scholars from PAR Sterile Products that are published in SciTechnol journals.
- Research Article: J Pharm Drug Deliv Res 2018
Simeon K. Adesina
Application of Acoustic- Vibratory Milling For Screening and Scale-Up of Micro/ Nanosuspensions in Early Drug Discovery and DevelopmentResearch Article: J Pharm Drug Deliv Res 2018
Hoang D Lu
Recombinant Human Insulin- PLGA NP Administered Orally after Combination with a Protease Inhibitor (N-Ethylmaleimide) in vivo ResultsLetter to Editor: J Pharm Drug Deliv Res 2018, 7:1
Abdelkader DH, El-Gizawyb SA, Faheemc AM, McCarrona PA, OsmanbK MA
Development and Validation of a Chromatographic Method for the Quantification of Isoniazid in Human PlasmaResearch Article: J Pharm Drug Deliv Res 2018, 7:1
Alshaikheid M, Fredj NB, Chaabane A, Chadli Z, Slama A, Boughattas N, Lassoued MA, Aouam K
Pharmacognostic Study of Seeds of Aconitum chasmanthum Stapf ex Holmes. A Wild Medicinal Plant of Neelum Valley Azad Jammu & Kashmir PakistanResearch Article: J Pharm Drug Deliv Res 2018, 7:1
Perveen A, Ijaz S, Ghaffar N